The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
2021 · npj Breast Cancer · 257 citations
https://doi.org/10.1038/s41523-021-00346-1
Y
Yuji Kozuka
Mie University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
1.3K
Citations
17
h-index
24
i10-index
Yuji Kozuka is an academic researcher from Mie University. The author has contributed to research in topics: Breast Lesions and Carcinomas & Breast Cancer Treatment Studies & Cancer Immunotherapy and Biomarkers. The author has an h-index of 17, co-authored 54 publications.
ORCID: 0000-0002-1693-2852Papers by this author
worksBinding of αvβ1 and αvβ6 integrins to tenascin-C induces epithelial–mesenchymal transition-like change of breast cancer cells
2013 · Oncogenesis · 85 citations
https://doi.org/10.1038/oncsis.2013.27
Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtype
2010 · BMC Cancer · 41 citations
https://doi.org/10.1186/1471-2407-10-568
Antitumor and anticancer stem cell activity of a poly ADP-ribose polymerase inhibitor olaparib in breast cancer cells
2012 · Breast Cancer · 28 citations
https://doi.org/10.1007/s12282-012-0356-z
High tumor budding is a strong predictor of poor prognosis in the resected perihilar cholangiocarcinoma patients regardless of neoadjuvant therapy, showing survival similar to those without resection
2020 · BMC Cancer · 25 citations
https://doi.org/10.1186/s12885-020-6695-9
The Japanese Breast Cancer Society Clinical Practice Guideline for pathological diagnosis of breast cancer
2014 · Breast Cancer · 7 citations
https://doi.org/10.1007/s12282-014-0549-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat